Protara Therapeutics Q4 EPS $(0.37) Misses $(0.33) Estimate
Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.33) by 13.85 percent. This is a 22.92 percent increase over losses of $(0.48) per share